ID   GLIS2_HUMAN             Reviewed;         524 AA.
AC   Q9BZE0; B3KX84;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   07-APR-2021, entry version 162.
DE   RecName: Full=Zinc finger protein GLIS2;
DE   AltName: Full=GLI-similar 2;
DE   AltName: Full=Neuronal Krueppel-like protein;
GN   Name=GLIS2; Synonyms=NKL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=11738817; DOI=10.1016/s0378-1119(01)00764-8;
RA   Zhang F., Jetten A.M.;
RT   "Genomic structure of the gene encoding the human GLI-related, Kruppel-like
RT   zinc finger protein GLIS2.";
RL   Gene 280:49-57(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   IDENTIFICATION.
RX   PubMed=11262234;
RA   Lamar E., Kintner C., Goulding M.;
RT   "Identification of NKL, a novel Gli-Kruppel zinc-finger protein that
RT   promotes neuronal differentiation.";
RL   Development 128:1335-1346(2001).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=17289029; DOI=10.1016/j.febslet.2007.01.058;
RA   Kim Y.-S., Kang H.S., Jetten A.M.;
RT   "The Kruppel-like zinc finger protein Glis2 functions as a negative
RT   modulator of the Wnt/beta-catenin signaling pathway.";
RL   FEBS Lett. 581:858-864(2007).
RN   [7]
RP   INTERACTION WITH CTNND1.
RX   PubMed=17344476; DOI=10.1091/mbc.e06-10-0941;
RA   Hosking C.R., Ulloa F., Hogan C., Ferber E.C., Figueroa A., Gevaert K.,
RA   Birchmeier W., Briscoe J., Fujita Y.;
RT   "The transcriptional repressor Glis2 is a novel binding partner for p120
RT   catenin.";
RL   Mol. Biol. Cell 18:1918-1927(2007).
RN   [8]
RP   INVOLVEMENT IN NPHP7.
RX   PubMed=17618285; DOI=10.1038/ng2072;
RA   Attanasio M., Uhlenhaut N.H., Sousa V.H., O'Toole J.F., Otto E., Anlag K.,
RA   Klugmann C., Treier A.-C., Helou J., Sayer J.A., Seelow D., Nuernberg G.,
RA   Becker C., Chudley A.E., Nuernberg P., Hildebrandt F., Treier M.;
RT   "Loss of GLIS2 causes nephronophthisis in humans and mice by increased
RT   apoptosis and fibrosis.";
RL   Nat. Genet. 39:1018-1024(2007).
CC   -!- FUNCTION: Can act either as a transcriptional repressor or as a
CC       transcriptional activator, depending on the cell context. Acts as a
CC       repressor of the Hedgehog signaling pathway (By similarity). Represses
CC       the Hedgehog-dependent expression of Wnt4 (By similarity). Necessary to
CC       maintain the differentiated epithelial phenotype in renal cells through
CC       the inhibition of SNAI1, which itself induces the epithelial-to-
CC       mesenchymal transition (By similarity). Represses transcriptional
CC       activation mediated by CTNNB1 in the Wnt signaling pathway. May act by
CC       recruiting the corepressors CTBP1 and HDAC3. May be involved in neuron
CC       differentiation (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with CTBP1 and HDAC3 (By similarity). Interacts with
CC       CTNNB1 (By similarity). Interacts with SUFU (By similarity). Interacts
CC       with CTNND1. {ECO:0000250, ECO:0000269|PubMed:17344476}.
CC   -!- INTERACTION:
CC       Q9BZE0; Q08043: ACTN3; NbExp=3; IntAct=EBI-7251368, EBI-2880652;
CC       Q9BZE0; Q6PJH3: AKAP9; NbExp=3; IntAct=EBI-7251368, EBI-11745576;
CC       Q9BZE0; Q8N2N9-4: ANKRD36B; NbExp=3; IntAct=EBI-7251368, EBI-12170453;
CC       Q9BZE0; Q03989: ARID5A; NbExp=3; IntAct=EBI-7251368, EBI-948603;
CC       Q9BZE0; P56945: BCAR1; NbExp=3; IntAct=EBI-7251368, EBI-702093;
CC       Q9BZE0; Q5BKX5-3: C19orf54; NbExp=5; IntAct=EBI-7251368, EBI-11976299;
CC       Q9BZE0; Q03060-25: CREM; NbExp=3; IntAct=EBI-7251368, EBI-12884642;
CC       Q9BZE0; O43186: CRX; NbExp=3; IntAct=EBI-7251368, EBI-748171;
CC       Q9BZE0; P67870: CSNK2B; NbExp=3; IntAct=EBI-7251368, EBI-348169;
CC       Q9BZE0; P56545-3: CTBP2; NbExp=3; IntAct=EBI-7251368, EBI-10171902;
CC       Q9BZE0; P35222: CTNNB1; NbExp=6; IntAct=EBI-7251368, EBI-491549;
CC       Q9BZE0; A1KXE4-2: FAM168B; NbExp=3; IntAct=EBI-7251368, EBI-12193763;
CC       Q9BZE0; P53539: FOSB; NbExp=3; IntAct=EBI-7251368, EBI-2806743;
CC       Q9BZE0; O75496: GMNN; NbExp=3; IntAct=EBI-7251368, EBI-371669;
CC       Q9BZE0; A6NEM1: GOLGA6L9; NbExp=3; IntAct=EBI-7251368, EBI-5916454;
CC       Q9BZE0; Q86YR5-3: GPSM1; NbExp=3; IntAct=EBI-7251368, EBI-10261098;
CC       Q9BZE0; Q7Z4W3: KRTAP19-3; NbExp=3; IntAct=EBI-7251368, EBI-12020132;
CC       Q9BZE0; Q3LI72: KRTAP19-5; NbExp=5; IntAct=EBI-7251368, EBI-1048945;
CC       Q9BZE0; Q3SYF9: KRTAP19-7; NbExp=3; IntAct=EBI-7251368, EBI-10241353;
CC       Q9BZE0; Q3LI64: KRTAP6-1; NbExp=3; IntAct=EBI-7251368, EBI-12111050;
CC       Q9BZE0; Q3LI66: KRTAP6-2; NbExp=5; IntAct=EBI-7251368, EBI-11962084;
CC       Q9BZE0; Q8IUC2: KRTAP8-1; NbExp=3; IntAct=EBI-7251368, EBI-10261141;
CC       Q9BZE0; Q9Y5B8: NME7; NbExp=3; IntAct=EBI-7251368, EBI-744782;
CC       Q9BZE0; O43482: OIP5; NbExp=3; IntAct=EBI-7251368, EBI-536879;
CC       Q9BZE0; Q9UF11-2: PLEKHB1; NbExp=3; IntAct=EBI-7251368, EBI-12832742;
CC       Q9BZE0; Q96CS7: PLEKHB2; NbExp=5; IntAct=EBI-7251368, EBI-373552;
CC       Q9BZE0; P78424: POU6F2; NbExp=3; IntAct=EBI-7251368, EBI-12029004;
CC       Q9BZE0; P31321: PRKAR1B; NbExp=3; IntAct=EBI-7251368, EBI-2805516;
CC       Q9BZE0; P86480: PRR20D; NbExp=3; IntAct=EBI-7251368, EBI-12754095;
CC       Q9BZE0; P57052: RBM11; NbExp=3; IntAct=EBI-7251368, EBI-741332;
CC       Q9BZE0; Q93062-3: RBPMS; NbExp=3; IntAct=EBI-7251368, EBI-740343;
CC       Q9BZE0; O15266-2: SHOX; NbExp=3; IntAct=EBI-7251368, EBI-12825957;
CC       Q9BZE0; Q08117-2: TLE5; NbExp=3; IntAct=EBI-7251368, EBI-11741437;
CC       Q9BZE0; Q86WV8: TSC1; NbExp=3; IntAct=EBI-7251368, EBI-12806590;
CC       Q9BZE0; Q8WVJ9: TWIST2; NbExp=3; IntAct=EBI-7251368, EBI-1797313;
CC       Q9BZE0; Q08AM6: VAC14; NbExp=3; IntAct=EBI-7251368, EBI-2107455;
CC       Q9BZE0; P61758: VBP1; NbExp=3; IntAct=EBI-7251368, EBI-357430;
CC       Q9BZE0; O95231: VENTX; NbExp=3; IntAct=EBI-7251368, EBI-10191303;
CC       Q9BZE0; Q9NZC7-5: WWOX; NbExp=3; IntAct=EBI-7251368, EBI-12040603;
CC       Q9BZE0; Q9UGI0: ZRANB1; NbExp=3; IntAct=EBI-7251368, EBI-527853;
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000250}. Cytoplasm
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in kidney and at low
CC       levels in heart, lung and placenta. Expressed in colon.
CC       {ECO:0000269|PubMed:11738817, ECO:0000269|PubMed:17289029}.
CC   -!- DOMAIN: The C2H2-type zinc finger 1 has a major repressor function and
CC       is required for CTNNB1 binding. {ECO:0000250}.
CC   -!- PTM: C-terminus cleavage is induced by interaction with CTNND1 and
CC       enhanced by Src tyrosine kinase. {ECO:0000250}.
CC   -!- DISEASE: Nephronophthisis 7 (NPHP7) [MIM:611498]: An autosomal
CC       recessive disorder resulting in end-stage renal disease during
CC       childhood or adolescence. It is a progressive tubulo-interstitial
CC       kidney disorder histologically characterized by modifications of the
CC       tubules with thickening of the basement membrane, interstitial fibrosis
CC       and, in the advanced stages, medullary cysts.
CC       {ECO:0000269|PubMed:17618285}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the GLI C2H2-type zinc-finger protein family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF325914; AAK00954.1; -; mRNA.
DR   EMBL; AK126918; BAG54396.1; -; mRNA.
DR   EMBL; AC005356; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC012676; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471112; EAW85317.1; -; Genomic_DNA.
DR   EMBL; CH471112; EAW85318.1; -; Genomic_DNA.
DR   CCDS; CCDS10511.1; -.
DR   RefSeq; NP_001305847.1; NM_001318918.1.
DR   RefSeq; NP_115964.2; NM_032575.2.
DR   RefSeq; XP_005255698.1; XM_005255641.4.
DR   SMR; Q9BZE0; -.
DR   BioGRID; 124182; 97.
DR   CORUM; Q9BZE0; -.
DR   IntAct; Q9BZE0; 47.
DR   MINT; Q9BZE0; -.
DR   STRING; 9606.ENSP00000262366; -.
DR   iPTMnet; Q9BZE0; -.
DR   PhosphoSitePlus; Q9BZE0; -.
DR   BioMuta; GLIS2; -.
DR   DMDM; 296434515; -.
DR   jPOST; Q9BZE0; -.
DR   MassIVE; Q9BZE0; -.
DR   MaxQB; Q9BZE0; -.
DR   PaxDb; Q9BZE0; -.
DR   PeptideAtlas; Q9BZE0; -.
DR   PRIDE; Q9BZE0; -.
DR   ProteomicsDB; 79818; -.
DR   Antibodypedia; 11033; 117 antibodies.
DR   DNASU; 84662; -.
DR   Ensembl; ENST00000262366; ENSP00000262366; ENSG00000126603.
DR   Ensembl; ENST00000433375; ENSP00000395547; ENSG00000126603.
DR   Ensembl; ENST00000612491; ENSP00000484027; ENSG00000274636.
DR   Ensembl; ENST00000633051; ENSP00000488242; ENSG00000274636.
DR   GeneID; 84662; -.
DR   KEGG; hsa:84662; -.
DR   UCSC; uc002cwc.2; human.
DR   CTD; 84662; -.
DR   DisGeNET; 84662; -.
DR   GeneCards; GLIS2; -.
DR   GeneReviews; GLIS2; -.
DR   HGNC; HGNC:29450; GLIS2.
DR   HPA; ENSG00000126603; Low tissue specificity.
DR   MalaCards; GLIS2; -.
DR   MIM; 608539; gene.
DR   MIM; 611498; phenotype.
DR   neXtProt; NX_Q9BZE0; -.
DR   OpenTargets; ENSG00000126603; -.
DR   Orphanet; 329469; Acute megakaryoblastic leukemia without Down syndrome.
DR   Orphanet; 93592; Juvenile nephronophthisis.
DR   PharmGKB; PA134919876; -.
DR   VEuPathDB; HostDB:ENSG00000126603.8; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000158383; -.
DR   HOGENOM; CLU_031801_1_0_1; -.
DR   InParanoid; Q9BZE0; -.
DR   OMA; APKDKCL; -.
DR   OrthoDB; 1318335at2759; -.
DR   PhylomeDB; Q9BZE0; -.
DR   TreeFam; TF351425; -.
DR   PathwayCommons; Q9BZE0; -.
DR   SignaLink; Q9BZE0; -.
DR   SIGNOR; Q9BZE0; -.
DR   BioGRID-ORCS; 84662; 13 hits in 1015 CRISPR screens.
DR   ChiTaRS; GLIS2; human.
DR   GenomeRNAi; 84662; -.
DR   Pharos; Q9BZE0; Tbio.
DR   PRO; PR:Q9BZE0; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q9BZE0; protein.
DR   Bgee; ENSG00000126603; Expressed in placenta and 189 other tissues.
DR   Genevisible; Q9BZE0; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0097730; C:non-motile cilium; IEA:Ensembl.
DR   GO; GO:0016607; C:nuclear speck; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; ISS:BHF-UCL.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISS:BHF-UCL.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; ISS:BHF-UCL.
DR   GO; GO:0061005; P:cell differentiation involved in kidney development; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; IBA:GO_Central.
DR   GO; GO:0061484; P:hematopoietic stem cell homeostasis; IEA:Ensembl.
DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; ISS:BHF-UCL.
DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0060994; P:regulation of transcription from RNA polymerase II promoter involved in kidney development; IEA:Ensembl.
DR   InterPro; IPR030432; Glis2.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR19818:SF84; PTHR19818:SF84; 1.
DR   Pfam; PF00096; zf-C2H2; 3.
DR   SMART; SM00355; ZnF_C2H2; 5.
DR   SUPFAM; SSF57667; SSF57667; 3.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 4.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 4.
PE   1: Evidence at protein level;
KW   Activator; Ciliopathy; Cytoplasm; Developmental protein; Differentiation;
KW   DNA-binding; Metal-binding; Nephronophthisis; Neurogenesis; Nucleus;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..524
FT                   /note="Zinc finger protein GLIS2"
FT                   /id="PRO_0000286983"
FT   ZN_FING         168..193
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         202..229
FT                   /note="C2H2-type 2; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         235..257
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         263..287
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         293..317
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          35..174
FT                   /note="Interaction with CTNND1"
FT                   /evidence="ECO:0000250"
FT   REGION          71..137
FT                   /note="Transcription activation"
FT                   /evidence="ECO:0000250"
FT   REGION          148..171
FT                   /note="Transcription repression"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        363..460
FT                   /note="Gly-rich"
FT   SITE            287..288
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000250"
FT   VARIANT         492
FT                   /note="T -> A (in dbSNP:rs8057701)"
FT                   /id="VAR_032256"
FT   CONFLICT        49
FT                   /note="P -> L (in Ref. 1; AAK00954)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   524 AA;  55689 MW;  F38BA80C477FDC24 CRC64;
     MHSLDEPLDL KLSITKLRAA REKRERTLGV VRPRALHREL GLVDDSPTPG SPGSPPSGFL
     LNSKFPEKVE GRFSAAPLVD LSLSPPSGLD SPNGSSSLSP ERQGNGDLPP VPSASDFQPL
     RYLDGVPSSF QFFLPLGSGG ALHLPASSFL TPPKDKCLSP DLPLPKQLVC RWAKCNQLFE
     LLQDLVDHVN DYHVKPEKDA GYCCHWEGCA RHGRGFNARY KMLIHIRTHT NEKPHRCPTC
     SKSFSRLENL KIHNRSHTGE KPYVCPYEGC NKRYSNSSDR FKHTRTHYVD KPYYCKMPGC
     HKRYTDPSSL RKHIKAHGHF VSHEQQELLQ LRPPPKPPLP APDGGPYVSG AQIIIPNPAA
     LFGGPGLPGL PLPLAPGPLD LSALACGNGG GSGGGGGMGP GLPGPVLPLN LAKNPLLPSP
     FGAGGLGLPV VSLLAGAAGG KAEGEKGRGS VPTRALGMEG HKTPLERTES SCSRPSPDGL
     PLLPGTVLDL STGVNSAASS PEALAPGWVV IPPGSVLLKP AVVN
//
